Cargando…

Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study

BACKGROUND: Oral anticoagulants are commonly used high-risk medications, but little is known about their safety in transition from hospital to home. Our objective was to measure the rates of hemorrhage and thromboembolic events among older adults receiving oral anticoagulant treatment early after ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holbrook, Anne, Benipal, Harsukh, Paterson, J. Michael, Martins, Diana, Greaves, Simon, Lee, Munil, Gomes, Tara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Joule Inc. or its licensors 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084547/ https://www.ncbi.nlm.nih.gov/pubmed/33863794 http://dx.doi.org/10.9778/cmajo.20200138

Ejemplares similares

Predictors of oral anticoagulant-associated adverse events in seniors transitioning from hospital to home: a retrospective cohort study protocol
por: Benipal, Harsukh, et al.
Publicado: (2020)

Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study
por: Wang, Mei, et al.
Publicado: (2022)

Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding
por: Little, Derek H.W., et al.
Publicado: (2021)

Mortality and oral anticoagulants in the Food and Drug Administration Adverse Event Reporting System
por: Serebruany, Victor, et al.
Publicado: (2017)

Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants
por: Gao, Lulu, et al.
Publicado: (2017)

The association between adverse events in later life and mortality in older individuals
por: Nilaweera, Dinuli, et al.
Publicado: (2023)

Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis
por: Maura, Géric, et al.
Publicado: (2018)

Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): protocol for a pilot randomised controlled trial
por: Holbrook, Anne M., et al.
Publicado: (2022)

Frailty and subsequent adverse outcomes in older patients with atrial fibrillation treated with oral anticoagulants: The Shizuoka study
por: Nishimura, Shiori, et al.
Publicado: (2023)

Direct Oral Anticoagulants as the First Choice of Anticoagulation for Patients with Peripheral Artery Disease to Prevent Adverse Vascular Events: A Systematic Review and Meta-Analysis
por: Pomozi, Enikő, et al.
Publicado: (2023)

Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review()
por: Li, Allen, et al.
Publicado: (2020)

The association of post-discharge adverse events with timely follow-up visits after hospital discharge
por: Tsilimingras, Dennis, et al.
Publicado: (2017)

Characteristics of ambulatory anticoagulant adverse drug events: a descriptive study
por: Long, Andrea L, et al.
Publicado: (2010)

Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism
por: Cambron, Julia C., et al.
Publicado: (2020)

Comparison of direct oral anticoagulants and warfarin regarding midterm adverse events in patients with atrial fibrillation undergoing catheter ablation
por: Sagawa, Yuichiro, et al.
Publicado: (2018)

Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function
por: Pham, Phuong, et al.
Publicado: (2020)

Clinical Characteristics, Patterns of Use, and incidence of Adverse Events in Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants in Colombia
por: Machado-Duque, Manuel E, et al.
Publicado: (2023)

Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database
por: Shimada, Kazuyo, et al.
Publicado: (2019)

Relative risks of adverse events among older adults receiving opioids versus NSAIDs after hospital discharge: A nationwide cohort study
por: Herzig, Shoshana J., et al.
Publicado: (2021)

Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010–2013)
por: Carrasco-Garrido, P, et al.
Publicado: (2017)

Practice Gap in Atrial Fibrillation Oral Anticoagulation Prescribing at Emergency Department Home Discharge
por: Kea, Bory, et al.
Publicado: (2020)

Prescribing trends of oral anticoagulants in England over the last decade: a focus on new and old drugs and adverse events reporting
por: Afzal, Saima, et al.
Publicado: (2021)

Analysis of Adverse Events in the Treatment of Patients with Non-Valvular Atrial Fibrillation with Oral Anticoagulants: Data from the “ANTEY” Observational Study
por: Martsevich, Sergey Yu., et al.
Publicado: (2022)

Comparability of Objective Structured Clinical Examinations (OSCEs) and Written Tests for Assessing Medical School Students’ Competencies: A Scoping Review
por: Chang, Oswin, et al.
Publicado: (2023)

Clinical outcome and predictors of adverse events of an enhanced older adult psychiatric liaison service: Rapid Assessment Interface and Discharge (Newport)
por: Singh, Inderpal, et al.
Publicado: (2016)

Preventing drug-related adverse events following hospital discharge: the role of the pharmacist
por: Nicholls, Justine, et al.
Publicado: (2017)

Comparison of bleeding risks among non-vitamin K antagonist oral anticoagulants using the Korea adverse event reporting system database
por: Ko, Young-Jin, et al.
Publicado: (2019)

Barriers and facilitators for optimizing oral anticoagulant management: Perspectives of patients, caregivers, and providers
por: Holbrook, Anne, et al.
Publicado: (2021)

Integration of the social determinants of health into quality indicators for colorectal cancer surgery: a scoping review protocol
por: Bondzi-Simpson, Adom, et al.
Publicado: (2023)

A retrospective study of adverse drug events in anticoagulant administration with relevance to COVID-19()
por: Patel, Purva, et al.
Publicado: (2023)

Childhood adverse events and BDNF promoter methylation in later-life
por: Zhou, Aoshuang, et al.
Publicado: (2023)

Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge
por: Qazi, Jakub Z., et al.
Publicado: (2021)

Parenteral and oral anticoagulant treatment for hospitalized and post-discharge patients with COVID-19: A systematic review
por: Tunjungputri, Rahajeng N., et al.
Publicado: (2021)

Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients Aged 80 Years and Older
por: Manckoundia, Patrick, et al.
Publicado: (2021)

Underestimated Ischemic Heart Disease in Major Adverse Cardiovascular Events after Septicemia Discharge
por: Hsiao, Chih-Chun, et al.
Publicado: (2022)

Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic
por: Donaldson, Mark, et al.
Publicado: (2013)

Potential Reduction in Adverse Events and Cost with Novel Anticoagulants among Patients with Acute Limb Ischemia
por: Freeman, Scott, et al.
Publicado: (2022)

Acute and Delayed Intracranial Hemorrhage in Head-Injured Patients on Warfarin versus Direct Oral Anticoagulant Therapy
por: Hughes, Patrick G., et al.
Publicado: (2021)

Causes and predictors of early readmission after percutaneous coronary intervention among patients discharged on oral anticoagulant therapy
por: Vidula, Mahesh K., et al.
Publicado: (2018)

Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
por: Wallvik, Niklas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l2676mh78iiv9ruta16ehgktj2